A randomized, double-blind, four-arm parallel-group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension : the REZALT study

• OGIHARA Toshio

  Osaka General Medical Center, Osaka Prefectural Hospital Organization

• SARUTA Takao

  Department of Internal Medicine, School of Medicine, Keio University

• SHIMADA Kazuyuki

  Department of Medicine, Jichi Medical University

• KURAMOTO Kizuku

  Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology

収録刊行物

• Hypertension research : clinical and experimental : official journal of the Japanese Society of Hypertension

  Hypertension research : clinical and experimental : official journal of the Japanese Society of Hypertension 32 (12), 1148-1154, 2009-12-01

キーワード

• ambulatory blood pressure monitoring
• azelnidipine
• combination therapy
• essential hypertension
• olmesartan medoxomil

詳細情報

• CRID: 1572543025892036864
• NII論文ID: 10026125220
• NII書誌ID: AA10847079
• ISSN: 09169636
• Web Site: https://search.jamas.or.jp/link/ui/2010128440
• 本文言語コード: en
• データソース種別:
  • CiNii Articles